For too long, research has treated men’s bodies as the default and women’s bodies as an afterthought. When it comes to conditions that primarily affect women, or affect women differently than men, there’s still a lot we don’t know about how to diagnose and treat them. Cardiovascular disease, for example, is the leading cause of death for women globally, yet providers aren’t fully equipped to understand how it shows up differently in women compared to men.
As part of our efforts to accelerate breakthroughs in women’s health and well-being, Pivotal and Wellcome Leap committed a total of $100 million to research conditions impacting women’s lives, including cardiovascular health.
With Wellcome Leap’s proven model, which brings together groups of experts from different sectors and industries to pursue bold goals on ambitious timelines, we expect to see outcomes years—even decades—sooner than we would through other approaches.
?
